Kudo M - Search Results

1

Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial.

Bruix J, Qin S, Merle P, Granito A, Huang YH, Bodoky G, Pracht M, Yokosuka O, Rosmorduc O, Breder V, Gerolami R, Masi G, Ross PJ, Song T, Bronowicki JP, Ollivier-Hourmand I, Kudo M, Cheng AL, Llovet JM, Finn RS, LeBerre MA, Baumhauer A, Meinhardt G, Han G; RESORCE Investigators. Bruix J, et al. Among authors: kudo m. Lancet. 2017 Jan 7;389(10064):56-66. doi: 10.1016/S0140-6736(16)32453-9. Epub 2016 Dec 6. Lancet. 2017. PMID: 27932229 Clinical Trial.

2

Initial treatment response is essential to improve survival in patients with hepatocellular carcinoma who underwent curative radiofrequency ablation therapy.

Takahashi S, Kudo M, Chung H, Inoue T, Ishikawa E, Kitai S, Tatsumi C, Ueda T, Minami Y, Ueshima K, Haji S. Takahashi S, et al. Among authors: kudo m. Oncology. 2007;72 Suppl 1:98-103. doi: 10.1159/000111714. Epub 2007 Dec 13. Oncology. 2007. PMID: 18087189

3

Combination therapy with S-1 and pegylated interferon alpha for advanced hepatocellular carcinoma.

Ueshima K, Kudo M, Nagai T, Tatsumi C, Ueda T, Takahashi S, Hatanaka K, Kitai S, Ishikawa E, Inoue T, Hagiwara S, Minami Y, Chung H. Ueshima K, et al. Among authors: kudo m. Oncology. 2008;75 Suppl 1:106-13. doi: 10.1159/000173431. Epub 2008 Dec 17. Oncology. 2008. PMID: 19092279

4

Management of hepatocellular carcinoma: from prevention to molecular targeted therapy.

Kudo M. Kudo M. Oncology. 2010 Jul;78 Suppl 1:1-6. doi: 10.1159/000315222. Epub 2010 Jul 8. Oncology. 2010. PMID: 20616576

5

Hepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma.

Ueshima K, Kudo M, Takita M, Nagai T, Tatsumi C, Ueda T, Kitai S, Ishikawa E, Yada N, Inoue T, Hagiwara S, Minami Y, Chung H. Ueshima K, et al. Among authors: kudo m. Oncology. 2010 Jul;78 Suppl 1:148-53. doi: 10.1159/000315244. Epub 2010 Jul 8. Oncology. 2010. PMID: 20616598 Clinical Trial.

6

Positioning of a molecular-targeted agent, sorafenib, in the treatment algorithm for hepatocellular carcinoma and implication of many complete remission cases in Japan.

Kudo M, Ueshima K. Kudo M, et al. Oncology. 2010 Jul;78 Suppl 1:154-66. doi: 10.1159/000315245. Epub 2010 Jul 8. Oncology. 2010. PMID: 20616599 Review.

7

Liver Cancer Working Group report.

Kudo M, Han KH, Kokudo N, Cheng AL, Choi BI, Furuse J, Izumi N, Park JW, Poon RT, Sakamoto M. Kudo M, et al. Jpn J Clin Oncol. 2010 Sep;40 Suppl 1:i19-27. doi: 10.1093/jjco/hyq123. Jpn J Clin Oncol. 2010. PMID: 20870915

8

Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009.

Yokosuka O, Kurosaki M, Imazeki F, Arase Y, Tanaka Y, Chayama K, Tanaka E, Kumada H, Izumi N, Mizokami M, Kudo M. Yokosuka O, et al. Among authors: kudo m. Hepatol Res. 2011 Jan;41(1):1-21. doi: 10.1111/j.1872-034X.2010.00739.x. Epub 2010 Nov 11. Hepatol Res. 2011. PMID: 21070536

9

The challenge of prognosis and staging for hepatocellular carcinoma.

Marrero JA, Kudo M, Bronowicki JP. Marrero JA, et al. Among authors: kudo m. Oncologist. 2010;15 Suppl 4:23-33. doi: 10.1634/theoncologist.2010-S4-23. Oncologist. 2010. PMID: 21115578 Free article. Review.

10

[Hepatocellular carcinoma].

Kudo M. Kudo M. Nihon Geka Gakkai Zasshi. 2011 Mar;112(2):122-9. Nihon Geka Gakkai Zasshi. 2011. PMID: 21488346 Review. Japanese. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,472 results

Search Page